Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
FDA warns about supplement GMP violations; ERSP asks Lunada to pull Amberen claims; supplement disease claims axed in U.K.; Herbalife recalls mislabeled mixes; authentic and counterfeit Maxiloss Weight Advanced on recall; MHRA warns of poison Chinese medicines.
You may also be interested in...
In Brief
Appropriations subcommittee largely ignores FDA; analysts predict lower Novartis OTC sales; France tightens advertising rules; NAD weighs in on Lunada claims; Global Biotechnologies supplements seized; Tetley tea faces lawsuit for antioxidant claims; more news In Brief.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.